Gregg Fonarow MD @gcfmd Ā· 02 Sep 2026
š« Statins for primary prevention: 4 RCTs, 3 decades AFCAPSāJUPITERāHOPE-3āSTAREE š 24ā44% ā major CV events Even at baseline LDL (108 mg/dL) No heterogeneity across subgroups in RRR āØš° Safety ā placebo, few exceptions āØāļø Benefits ā« risks š cost $30/year https://t.co/cFVgoFRxRe
17 297Views
228Likes
66Reposts
10Replies
3Quotes
127Bookmarks
Is that a lot?
8.79Ćvs this author's median1 968 views is typical
80Percentile for this authorof 5 recent posts
5.51Ćvs 10Kā100K median3 137 views is typical
139.02%Reachviews Ć· followers
1.77%Engagement rateof viewers reacted